- Home
- NXJ vs TERN Comparison
NXJ vs TERN Comparison
Compare NXJ & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXJ
- TERN
- Stock Information
- Founded
- NXJ 1999
- TERN 2017
- Country
- NXJ United States
- TERN United States
- Employees
- NXJ N/A
- TERN N/A
- Industry
- NXJ Finance/Investors Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- NXJ Finance
- TERN Health Care
- Exchange
- NXJ Nasdaq
- TERN Nasdaq
- Market Cap
- NXJ 457.7M
- TERN 634.5M
- IPO Year
- NXJ N/A
- TERN 2021
- Fundamental
- Price
- NXJ $11.41
- TERN $6.96
- Analyst Decision
- NXJ
- TERN Buy
- Analyst Count
- NXJ 0
- TERN 5
- Target Price
- NXJ N/A
- TERN $15.63
- AVG Volume (30 Days)
- NXJ 74.9K
- TERN 1.2M
- Earning Date
- NXJ 01-01-0001
- TERN 08-05-2025
- Dividend Yield
- NXJ 3.27%
- TERN N/A
- EPS Growth
- NXJ N/A
- TERN N/A
- EPS
- NXJ N/A
- TERN N/A
- Revenue
- NXJ N/A
- TERN N/A
- Revenue This Year
- NXJ N/A
- TERN N/A
- Revenue Next Year
- NXJ N/A
- TERN N/A
- P/E Ratio
- NXJ N/A
- TERN N/A
- Revenue Growth
- NXJ N/A
- TERN N/A
- 52 Week Low
- NXJ $10.06
- TERN $1.87
- 52 Week High
- NXJ $12.24
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- NXJ 50.69
- TERN 59.78
- Support Level
- NXJ $11.12
- TERN $6.23
- Resistance Level
- NXJ $11.52
- TERN $7.32
- Average True Range (ATR)
- NXJ 0.08
- TERN 0.42
- MACD
- NXJ -0.01
- TERN -0.01
- Stochastic Oscillator
- NXJ 47.50
- TERN 66.91
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.